Baldwin W, Livengood J, Giebler H, Stovall J, Boroughs K, Sonnberg S, et al. Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice. Sci Rep. 2018;8:16509 pubmed publisher

Müller J, Harms M, Krüger F, Groß R, Joas S, Hayn M, et al. Semen inhibits Zika virus infection of cells and tissues from the anogenital region. Nat Commun. 2018;9:2207 pubmed publisher

De La Guardia C, Stephens D, Dang H, Quijada M, Larionov O, Lleonart R. Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2. Molecules. 2018;23: pubmed publisher

Richard V, Aubry M. Method for simple and rapid concentration of Zika virus particles from infected cell-culture supernatants. J Virol Methods. 2018;255:82-83 pubmed publisher

Glasner D, Ratnasiri K, Puerta Guardo H, Espinosa D, Beatty P, Harris E. Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components. PLoS Pathog. 2017;13:e1006673 pubmed publisher

Yi G, Xu X, Abraham S, Petersen S, Guo H, Ortega N, et al. A DNA Vaccine Protects Human Immune Cells against Zika Virus Infection in Humanized Mice. EBioMedicine. 2017;25:87-94 pubmed publisher

Wang J, Bardelli M, Espinosa D, Pedotti M, Ng T, Bianchi S, et al. A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential. Cell. 2017;171:229-241.e15 pubmed publisher

Retallack H, Di Lullo E, Arias C, Knopp K, Laurie M, Sandoval Espinosa C, et al. Zika virus cell tropism in the developing human brain and inhibition by azithromycin. Proc Natl Acad Sci U S A. 2016;113:14408-14413 pubmed